<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04320498</url>
  </required_header>
  <id_info>
    <org_study_id>122</org_study_id>
    <nct_id>NCT04320498</nct_id>
  </id_info>
  <brief_title>Short Term Results of Platelet-rich Plasma in the Treatment of Chronic Anal Fissure</brief_title>
  <official_title>Effects of Platelet-rich Plasma in the Treatment of Chronic Anal Fissure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>KTO Karatay University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Istanbul Medipol University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>KTO Karatay University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Autologous PRP currently has many uses in surgical and medical therapy. Compared with other
      regenerative therapies, PRP is easy-to-prepare, low-cost, and does not require complex
      equipment. The use of autologous PRP avoids immunological side effects. Data is lacking on
      the use of PRP in the treatment of anal fissure. This study evaluated PRP as an alternative
      medical treatment for chronic anal fissures.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      . Chronic anal fissures are mucosal ulcers in the anal canal distal to the dentate line and
      most often present with severe pain and bleeding during defecation. The symptoms of chronic
      anal fissures persist for more than 8 weeks and do not respond well to medical treatment.
      This randomized controlled trial investigated the effects of PRP on the healing of chronic
      anal fissures, which can be considered as nonhealing ulcers. High anal sphincter pressure can
      cause chronic anal fissures by producing mucosal ischemia in the posterior anal canal that
      delays wound healing, ultimately resulting in a chronic nonhealing ulcer. Increased anal
      sphincter pressure induces constipation and spasms in the arterioles that form the mucosal
      blood supply.9 Botulinum toxin, calcium channel blockers, nitrates, or surgery promote
      healing by reducing anal sphincter pressure, and increasing blood flow.

      Autologous PRP has been shown to speed recovery and improve pain and quality of life scores
      of patients treated for chronic wounds.PRP reduced complaints and accelerated
      epithelialization and healing in patients with chronic anal fissures. PRP, which can be
      obtained easily and did not have any harmful patient effects may be an alternative to surgery
      in patients with chronic anal fissures. The duration of symptoms should be considered during
      the evaluation of treatment options.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">January 1, 2019</start_date>
  <completion_date type="Anticipated">December 15, 2020</completion_date>
  <primary_completion_date type="Actual">October 1, 2019</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>effects of PRP treatment on epithelization .</measure>
    <time_frame>10 days , 1 month and 2 months</time_frame>
    <description>In a clean surgical wound, the epithelial cells migrate downward to meet deep in the dermis. Migration ceases when the layer is rejuvenated. Following surgery, this process is normally complete within 48 hours. However, the process of epithelialization is difficult in wounds that are not primarily closed or need to heal by secondary intention. In these wounds, the physical distance of epithelial migration is increased across the length, width, and depth of the wound. In chronic anal fissures, wound epithelization can be evaluated by inspection. Approximately 80 percent of the original strength of the tissue is obtained by six weeks. So we planned to make this assessment on the 10th Day, 1st Month and 2nd Month for the reason I explained above. We considered the complete epithelization of the fissure as a complete healing. We evaluated patients with epithelialization in the midline but incomplete as partial epithelization.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>effect of PRP treatment on VAS scores</measure>
    <time_frame>10 days , 1 month and 2 months</time_frame>
    <description>Distribution of the effect of PRP treatment on VAS scores. The VAS is a simple scale with a length of 100 mm on which patients were asked to rate their pain from 0 (absence of pain) to 100 (worst pain imaginable).
In connection with wound healing, we expect the pain to decrease. The process of epithelialization is difficult in wounds that are not primarily closed or need to heal by secondary intention. In these wounds, the physical distance of epithelial migration is increased across the length, width, and depth of the wound. So we planned to make this assessment on the 10th Day to evaluate early pain control. we planned In the first month, in order to evaluate the middle period pain control and In the second month to evaluate the late period pain control.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>effect of PRP treatment on symptoms</measure>
    <time_frame>10 days , 1 month and 2 months</time_frame>
    <description>Distribution of the effect of PRP treatment on symptoms Presenting symptoms including constipation, pruritus, presence of skin tags and bleeding were recorded on enrolment. In connection with wound healing, we expect symptoms such as constipation, pruritus and bleeding to decrease. we assessed the decline in constipation, pruritus, and bleeding from the start of treatment. we record the symptoms of the patients on 10th Day , first month and second month. Thus, we compared the response to treatment in the early, middle and late periods.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison of the effect of treatments on pain according to the onset of symptoms of patients</measure>
    <time_frame>10 days , 1 month and 2 months</time_frame>
    <description>The duration of the associated complaints and symptoms distinguishes acute from chronic anal fissures, which are evaluated and treated as conditions with different etiologies and physiology. Acute anal fissures have symptoms of &lt; 8 weeks duration. Chronic anal fissure symptoms have persisted for 8 weeks or longer. The effectiveness of medical treatment decreases with time after the appearance of the first anal fissure symptoms and ultimately becomes less effective than surgery. we evaluated the effect of treatments on symptoms according to the onset of symptoms of patients. we evaluated VAS scores in day 10 , months 1 and 2 in patients with fissures for less than 12 months than in those with fissures of longer duration.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">41</enrollment>
  <condition>Anal Fissure Chronic</condition>
  <condition>PRP</condition>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The control patients self-administered topical glyceryl trinitrate, in the perianal area twice a day (Anrecta, Consentis Pharmaceuticals, Istanbul, Turkey)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PRP group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>PRP was injected locally in the anal fissure area and glyceryl trinitrate was administered twice daily in the perianal region as in the control group.</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>prp injection</intervention_name>
    <description>PRP was injected locally in the anal fissure area and glyceryl trinitrate was administered twice daily in the perianal region as in the control group.</description>
    <arm_group_label>PRP group</arm_group_label>
    <other_name>Platelet rich plasma injection</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Anrecta</intervention_name>
    <description>self-administered topical glyceryl trinitrate (anrecta), in the perianal area twice a day</description>
    <arm_group_label>PRP group</arm_group_label>
    <arm_group_label>control group</arm_group_label>
    <other_name>rectoderm</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>sitz bath</intervention_name>
    <description>participants were told to take a hot water sitz bath once a day</description>
    <arm_group_label>PRP group</arm_group_label>
    <arm_group_label>control group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>nutrition regulation</intervention_name>
    <description>The study participants were told to eat a fiber-rich diet and to drink least 2 liters of water daily</description>
    <arm_group_label>PRP group</arm_group_label>
    <arm_group_label>control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  between 18 and 65 years of age with painful defecation of at least 2 months duration
             and diagnosed with anal fissure between January and October 2019 were included.

          -  The diagnosis of chronic anal fissure required :

          -  the presence of internal sphincter muscle fibers in the base of the fissure

          -  hypertrophic anal papillae on digital rectal examination

        Exclusion Criteria:

          -  Patients with physical examination findings that did not meet the definition of
             chronic anal fissure

          -  with painful defecation for less than 2 months,

          -  atypical fissure location or multiple anal fissures away from the midline

          -  inflammatory bowel disease

          -  cancer

          -  history of trauma

          -  tuberculosis

          -  immune suppression

          -  sexually transmitted disease

          -  a disease possibly associated with a fissure

          -  a history of anal surgery

          -  previous treatment for anal fissure

          -  current pregnancy .
      </textblock>
    </criteria>
    <gender>All</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Between 18 and 65 years of age with chronic anal fissure were included</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Karatay Medicana Ãœniversitesi</name>
      <address>
        <city>Konya</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <reference>
    <citation>Altomare DF, Binda GA, Canuti S, Landolfi V, Trompetto M, Villani RD. The management of patients with primary chronic anal fissure: a position paper. Tech Coloproctol. 2011 Jun;15(2):135-41. doi: 10.1007/s10151-011-0683-7. Epub 2011 May 3. Review.</citation>
    <PMID>21538013</PMID>
  </reference>
  <reference>
    <citation>Gupta PJ. Closed anal sphincter manipulation technique for chronic anal fissure. Rev Gastroenterol Mex. 2008 Jan-Mar;73(1):29-32.</citation>
    <PMID>18792671</PMID>
  </reference>
  <reference>
    <citation>Nelson RL, Thomas K, Morgan J, Jones A. Non surgical therapy for anal fissure. Cochrane Database Syst Rev. 2012 Feb 15;(2):CD003431. doi: 10.1002/14651858.CD003431.pub3. Review.</citation>
    <PMID>22336789</PMID>
  </reference>
  <reference>
    <citation>Medhi B, Rao RS, Prakash A, Prakash O, Kaman L, Pandhi P. Recent advances in the pharmacotherapy of chronic anal fissure: an update. Asian J Surg. 2008 Jul;31(3):154-63. doi: 10.1016/S1015-9584(08)60078-0. Review.</citation>
    <PMID>18658016</PMID>
  </reference>
  <reference>
    <citation>Wu PI, Diaz R, Borg-Stein J. Platelet-Rich Plasma. Phys Med Rehabil Clin N Am. 2016 Nov;27(4):825-853. doi: 10.1016/j.pmr.2016.06.002. Review.</citation>
    <PMID>27788903</PMID>
  </reference>
  <reference>
    <citation>Dhillon RS, Schwarz EM, Maloney MD. Platelet-rich plasma therapy - future or trend? Arthritis Res Ther. 2012 Aug 8;14(4):219. doi: 10.1186/ar3914. Review.</citation>
    <PMID>22894643</PMID>
  </reference>
  <reference>
    <citation>Li F, Li Q, Wang LF. [Advances in the research of effects of mesenchymal stem cells, exosomes, and platelet-rich plasma in wound repair]. Zhonghua Shao Shang Za Zhi. 2019 Oct 20;35(10):764-768. doi: 10.3760/cma.j.issn.1009-2587.2019.10.012. Review. Chinese.</citation>
    <PMID>31658550</PMID>
  </reference>
  <reference>
    <citation>Etulain J, Mena HA, Meiss RP, Frechtel G, Gutt S, Negrotto S, Schattner M. An optimised protocol for platelet-rich plasma preparation to improve its angiogenic and regenerative properties. Sci Rep. 2018 Jan 24;8(1):1513. doi: 10.1038/s41598-018-19419-6.</citation>
    <PMID>29367608</PMID>
  </reference>
  <reference>
    <citation>Hancock BD. The internal sphincter and anal fissure. Br J Surg. 1977 Feb;64(2):92-5.</citation>
    <PMID>890253</PMID>
  </reference>
  <reference>
    <citation>EISENHAMMER S. The evaluation of the internal anal sphincterotomy operation with special reference to anal fissure. Surg Gynecol Obstet. 1959 Nov;109:583-90.</citation>
    <PMID>13819766</PMID>
  </reference>
  <reference>
    <citation>Notaras MJ. Lateral subcutaneous sphincterotomy for anal fissure--a new technique. Proc R Soc Med. 1969 Jul 7;62(7):713.</citation>
    <PMID>5803521</PMID>
  </reference>
  <reference>
    <citation>Casillas S, Hull TL, Zutshi M, Trzcinski R, Bast JF, Xu M. Incontinence after a lateral internal sphincterotomy: are we underestimating it? Dis Colon Rectum. 2005 Jun;48(6):1193-9.</citation>
    <PMID>15906136</PMID>
  </reference>
  <reference>
    <citation>Kang GS, Kim BS, Choi PS, Kang DW. Evaluation of healing and complications after lateral internal sphincterotomy for chronic anal fissure: marginal suture of incision vs. open left incision: prospective, randomized, controlled study. Dis Colon Rectum. 2008 Mar;51(3):329-33. doi: 10.1007/s10350-007-9122-2. Epub 2008 Jan 4.</citation>
    <PMID>18176828</PMID>
  </reference>
  <reference>
    <citation>Rattan S, Chakder S. Role of nitric oxide as a mediator of internal anal sphincter relaxation. Am J Physiol. 1992 Jan;262(1 Pt 1):G107-12.</citation>
    <PMID>1733256</PMID>
  </reference>
  <reference>
    <citation>Loder PB, Kamm MA, Nicholls RJ, Phillips RK. 'Reversible chemical sphincterotomy' by local application of glyceryl trinitrate. Br J Surg. 1994 Sep;81(9):1386-9.</citation>
    <PMID>7953427</PMID>
  </reference>
  <reference>
    <citation>Collins EE, Lund JN. A review of chronic anal fissure management. Tech Coloproctol. 2007 Sep;11(3):209-23. Epub 2007 Aug 3. Review.</citation>
    <PMID>17676270</PMID>
  </reference>
  <reference>
    <citation>Lund JN, Scholefield JH. A randomised, prospective, double-blind, placebo-controlled trial of glyceryl trinitrate ointment in treatment of anal fissure. Lancet. 1997 Jan 4;349(9044):11-4. Erratum in: Lancet 1997 Mar 1;349(9052):656.</citation>
    <PMID>8988115</PMID>
  </reference>
  <reference>
    <citation>Shah V, Lyford G, Gores G, Farrugia G. Nitric oxide in gastrointestinal health and disease. Gastroenterology. 2004 Mar;126(3):903-13. Review.</citation>
    <PMID>14988844</PMID>
  </reference>
  <reference>
    <citation>Wang HL, Avila G. Platelet rich plasma: myth or reality? Eur J Dent. 2007 Oct;1(4):192-4.</citation>
    <PMID>19212466</PMID>
  </reference>
  <reference>
    <citation>Masoudi E, Ribas J, Kaushik G, Leijten J, Khademhosseini A. Platelet-Rich Blood Derivatives for Stem Cell-Based Tissue Engineering and Regeneration. Curr Stem Cell Rep. 2016 Mar;2(1):33-42. doi: 10.1007/s40778-016-0034-8. Epub 2016 Feb 13.</citation>
    <PMID>27047733</PMID>
  </reference>
  <reference>
    <citation>Schouten WR, Briel JW, Auwerda JJ, De Graaf EJ. Ischaemic nature of anal fissure. Br J Surg. 1996 Jan;83(1):63-5.</citation>
    <PMID>8653368</PMID>
  </reference>
  <reference>
    <citation>Schouten WR, Briel JW, Auwerda JJ. Relationship between anal pressure and anodermal blood flow. The vascular pathogenesis of anal fissures. Dis Colon Rectum. 1994 Jul;37(7):664-9.</citation>
    <PMID>8026232</PMID>
  </reference>
  <reference>
    <citation>Margolis DJ, Kantor J, Santanna J, Strom BL, Berlin JA. Effectiveness of platelet releasate for the treatment of diabetic neuropathic foot ulcers. Diabetes Care. 2001 Mar;24(3):483-8.</citation>
    <PMID>11289472</PMID>
  </reference>
  <reference>
    <citation>Kazakos K, Lyras DN, Verettas D, Tilkeridis K, Tryfonidis M. The use of autologous PRP gel as an aid in the management of acute trauma wounds. Injury. 2009 Aug;40(8):801-5. doi: 10.1016/j.injury.2008.05.002. Epub 2008 Aug 13.</citation>
    <PMID>18703188</PMID>
  </reference>
  <reference>
    <citation>Dionyssiou D, Demiri E, Foroglou P, Cheva A, Saratzis N, Aivazidis C, Karkavelas G. The effectiveness of intralesional injection of platelet-rich plasma in accelerating the healing of chronic ulcers: an experimental and clinical study. Int Wound J. 2013 Aug;10(4):397-406. doi: 10.1111/j.1742-481X.2012.00996.x. Epub 2012 Jun 4.</citation>
    <PMID>22672105</PMID>
  </reference>
  <reference>
    <citation>Menchisheva Y, Mirzakulova U, Yui R. Use of platelet-rich plasma to facilitate wound healing. Int Wound J. 2019 Apr;16(2):343-353. doi: 10.1111/iwj.13034. Epub 2018 Nov 15.</citation>
    <PMID>30440099</PMID>
  </reference>
  <reference>
    <citation>Motie MR, Hashemi P. Chronic Anal Fissure: A Comparative Study of Medical Treatment Versus Surgical Sphincterotomy. Acta Med Iran. 2016 Jul;54(7):437-40.</citation>
    <PMID>27424014</PMID>
  </reference>
  <reference>
    <citation>Valizadeh N, Jalaly NY, Hassanzadeh M, Kamani F, Dadvar Z, Azizi S, Salehimarzijarani B. Botulinum toxin injection versus lateral internal sphincterotomy for the treatment of chronic anal fissure: randomized prospective controlled trial. Langenbecks Arch Surg. 2012 Oct;397(7):1093-8. doi: 10.1007/s00423-012-0948-2. Epub 2012 Mar 20.</citation>
    <PMID>22430300</PMID>
  </reference>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>March 12, 2020</study_first_submitted>
  <study_first_submitted_qc>March 21, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 25, 2020</study_first_posted>
  <last_update_submitted>March 21, 2020</last_update_submitted>
  <last_update_submitted_qc>March 21, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 25, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>KTO Karatay University</investigator_affiliation>
    <investigator_full_name>Yusuf Tanrikulu</investigator_full_name>
    <investigator_title>Assoc Professor</investigator_title>
  </responsible_party>
  <keyword>chronic anal fissure</keyword>
  <keyword>medical treatment</keyword>
  <keyword>platelet rich plasma</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fissure in Ano</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

